Plasma Rich in Growth Factors in Macular Hole Surgery

The aim of this study was to evaluate the use of PRGF (plasma rich in growth factors) as an adjuvant to PPV (pars plana vitrectomy) in recurrent, persistent, or poor prognosis MH (macular hole). Patients with MH were treated with PPV plus adjuvant therapy (PRGF membrane (mPRGF) and injectable liquid...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez-Ávila, Ronald M., Robayo-Esper, Carlos A., Villota-Deleu, Eva, Fernández-Vega Sanz, Álvaro, Fernández-Vega González, Álvaro, de la Sen-Corcuera, Borja, Anitua, Eduardo, Merayo-Lloves, Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788286/
https://www.ncbi.nlm.nih.gov/pubmed/35076502
http://dx.doi.org/10.3390/clinpract12010007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788286/
https://www.ncbi.nlm.nih.gov/pubmed/35076502
http://dx.doi.org/10.3390/clinpract12010007

Ejemplares similares